Doctor profile · Federal record

Dr. Jonathan Moreira, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Chicago, IL

  • NPI 1336371590
  • Accepts Medicare
  • MIPS 91.3 / 100 · 2023
  • 17 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1740 W Taylor St
Chicago, IL 606127232
(312) 996-1581
fax (312) 413-4131
Additional location
675 N Saint Clair St
Chicago, IL 606115975
(312) 926-6895
Mailing address
676 N. St Clair St, 850
Chicago, IL 60611

Credentials & registration

NPPES · NUCC
NPI registered
August 2009 — 17 yrs on file
Profile last updated
March 17, 2018
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Illinois #036.130504
Medicaid
MN #ENROLLED

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1336371590. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
5,993
Distinct HCPCS
10
Medicare allowed
$325,268
HCPCS Description Services Patients Avg allowed
J9271 Injection, pembrolizumab, 1 mg 4,400 16 $49
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 324 55 $83
J1100 Injection, dexamethasone sodium phosphate, 1 mg 246 20 $0
J2469 Injection, palonosetron hcl, 25 mcg 200 17 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 182 60 $132
99215 Established patient office or other outpatient visit, 40-54 minutes 137 35 $187
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 101 18 $6
96413 Administration of chemotherapy into vein, 1 hour or less 93 76 $136
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 76 28 $125
96375 Injection of additional new drug or substance into vein 70 36 $16

In context: peer comparison

Among 77 peers in this city , average services per provider: 870. This provider delivers 6.9× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,228
Transactions
2
Manufacturers
2
Payer (manufacturer) Industry Txns Amount
Kite Pharma, Inc. 1 $2,200.00
ABBVIE INC. 1 $27.94

By nature of payment

Consulting Fee
$2,200
Food and Beverage
$28

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
497
Patients
34
Total drug cost
$1,084,795
Drug Type Claims Patients Total cost
Valacyclovir (Valacyclovir Hcl) Brand 79 20 $4,817
Prednisone Generic 66 14 $567
Magnesium Sulfate Generic 59 0 $404
Ursodiol Generic 45 0 $5,358
Jakafi (Ruxolitinib Phosphate) Brand 32 0 $471,348
Acyclovir Generic 27 0 $336
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 27 0 $209
Gabapentin Generic 26 0 $743
Pantoprazole Sodium Generic 26 0 $520
Rezurock (Belumosudil Mesylate) Brand 24 0 $574,392

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jonathan Moreira's medical specialty?
Dr. Jonathan Moreira practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Jonathan Moreira practice?
Dr. Jonathan Moreira practices at 1740 W Taylor St, Chicago, IL 606127232. Office phone: 3129961581.
What is Dr. Jonathan Moreira's NPI?
Dr. Jonathan Moreira's National Provider Identifier (NPI) is 1336371590, issued by NPPES.
Does Dr. Jonathan Moreira accept Medicare assignment?
Yes. Dr. Jonathan Moreira accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jonathan Moreira commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.